News
MOSAIC at Bio-IT World Europe 2023
Read the article in BIO-IT World
November 29, 2023
On the 29th November 2023, Owkin’s Joseph Lehár and other experts in the field participated in a panel discussion at #BioITExpo about the scientific vision of MOSAIC and shared updates on the initiative’s first six months.
“A lot of people are doing generative AI without having a biology step,” says Thomas Clozel. The Owkin approach, instead, prioritizes biological discovery through AI across the entire drug discovery and development pipeline.
About MOSAIC
MOSAIC is a large-scale initiative that combines patient samples and technologies from multiple institutions, hospitals and technology partners, who are joining forces with Owkin to create the largest multimodal, spatial omics atlas in cancer.